BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24222686)

  • 1. BMP-9 balances endothelial cell fate.
    Derynck R; Akhurst RJ
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18746-7. PubMed ID: 24222686
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression.
    Yoshimatsu Y; Lee YG; Akatsu Y; Taguchi L; Suzuki HI; Cunha SI; Maruyama K; Suzuki Y; Yamazaki T; Katsura A; Oh SP; Zimmers TA; Lee SJ; Pietras K; Koh GY; Miyazono K; Watabe T
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18940-5. PubMed ID: 24133138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homeobox D3, A Novel Link Between Bone Morphogenetic Protein 9 and Transforming Growth Factor Beta 1 Signaling.
    Wang L; Yao J; Yu T; Zhang D; Qiao X; Yao Z; Wu X; Zhang L; Boström KI; Yao Y
    J Mol Biol; 2020 Mar; 432(7):2030-2041. PubMed ID: 32061928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoglin: Beyond the Endothelium.
    Schoonderwoerd MJA; Goumans MTH; Hawinkels LJAC
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32059544
    [No Abstract]   [Full Text] [Related]  

  • 5. BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo.
    Suzuki Y; Ohga N; Morishita Y; Hida K; Miyazono K; Watabe T
    J Cell Sci; 2010 May; 123(Pt 10):1684-92. PubMed ID: 20406889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis.
    Cunha SI; Pardali E; Thorikay M; Anderberg C; Hawinkels L; Goumans MJ; Seehra J; Heldin CH; ten Dijke P; Pietras K
    J Exp Med; 2010 Jan; 207(1):85-100. PubMed ID: 20065063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
    Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O
    Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cell differentiation by SOX17: promoting the tip cell or stalking its neighbor instead?
    Goveia J; Zecchin A; Rodriguez FM; Moens S; Stapor P; Carmeliet P
    Circ Res; 2014 Jul; 115(2):205-7. PubMed ID: 24989487
    [No Abstract]   [Full Text] [Related]  

  • 9. Signal transduction in angiogenesis.
    Zachary I
    EXS; 2005; (94):267-300. PubMed ID: 15617484
    [No Abstract]   [Full Text] [Related]  

  • 10. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
    Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P
    J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hemostatic system in angiogenesis.
    van Hinsbergh VW; Koolwijk P; Hoekman K
    EXS; 2005; (94):247-66. PubMed ID: 15617483
    [No Abstract]   [Full Text] [Related]  

  • 12. Dual targeting of vascular endothelial growth factor and bone morphogenetic protein-9/10 impairs tumor growth through inhibition of angiogenesis.
    Akatsu Y; Yoshimatsu Y; Tomizawa T; Takahashi K; Katsura A; Miyazono K; Watabe T
    Cancer Sci; 2017 Jan; 108(1):151-155. PubMed ID: 28133920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoglin mediates fibronectin/α5β1 integrin and TGF-β pathway crosstalk in endothelial cells.
    Tian H; Mythreye K; Golzio C; Katsanis N; Blobe GC
    EMBO J; 2012 Oct; 31(19):3885-900. PubMed ID: 22940691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
    Upton PD; Davies RJ; Trembath RC; Morrell NW
    J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches for studying angiogenesis-related signal transduction.
    Derakhshan B; Harrison KD; Miao QR; Sessa WC
    Methods Enzymol; 2008; 443():1-23. PubMed ID: 18772008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tips, stalks, tubes: notch-mediated cell fate determination and mechanisms of tubulogenesis during angiogenesis.
    Tung JJ; Tattersall IW; Kitajewski J
    Cold Spring Harb Perspect Med; 2012 Feb; 2(2):a006601. PubMed ID: 22355796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor and other signaling pathways in developmental and pathologic angiogenesis.
    Thurston G; Gale NW
    Int J Hematol; 2004 Jul; 80(1):7-20. PubMed ID: 15293563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bone Morphogenetic Protein (BMP)-derived Peptide Based on the Type I Receptor-binding Site Modifies Cell-type Dependent BMP Signalling.
    Tong Z; Guo J; Glen RC; Morrell NW; Li W
    Sci Rep; 2019 Sep; 9(1):13446. PubMed ID: 31530856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of lymphangiogenesis--from cell fate determination to vessel remodeling.
    Karpanen T; Mäkinen T
    Exp Cell Res; 2006 Mar; 312(5):575-83. PubMed ID: 16343484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting.
    van Meeteren LA; Thorikay M; Bergqvist S; Pardali E; Stampino CG; Hu-Lowe D; Goumans MJ; ten Dijke P
    J Biol Chem; 2012 May; 287(22):18551-61. PubMed ID: 22493445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.